Inhibikase Therapeutics, Inc. (IKT) Surges 5.2% on Heavy Volume
Market Performance Inhibikase Therapeutics, Inc. (NASDAQ:IKT) surged 5.2% in today's trading, closing at $2.33. The Healthcare stock traded 531,727.12152 shares, 2.6x its average…
Read more
